Franklin Prescriptions, Inc. v. the New York Times Co.

267 F. Supp. 2d 425, 32 Media L. Rep. (BNA) 1229, 2003 U.S. Dist. LEXIS 10617, 2003 WL 21404407
CourtDistrict Court, E.D. Pennsylvania
DecidedJune 19, 2003
DocketCivil Action 01-145
StatusPublished
Cited by8 cases

This text of 267 F. Supp. 2d 425 (Franklin Prescriptions, Inc. v. the New York Times Co.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Franklin Prescriptions, Inc. v. the New York Times Co., 267 F. Supp. 2d 425, 32 Media L. Rep. (BNA) 1229, 2003 U.S. Dist. LEXIS 10617, 2003 WL 21404407 (E.D. Pa. 2003).

Opinion

MEMORANDUM

RUFE, District Judge.

This is a defamation case brought by Franklin Prescriptions, Incorporated, (“Franklin”) against The New York Times Company (“The Times”) premised upon injury to Franklin’s reputation resulting from the publication of an article by The Times entitled A Web Bazaar Turns Into a Pharmaceutical Free For All. Presently before the Court is The Times’ Motion for Certification of Interlocutory Appeal or, in the alternative, For Reconsideration of the Court’s Denial of The Times’ Summary Judgment Motion. For the reasons set forth below, The Times’ Motion is denied in its entirety.

I. BACKGROUND

Franklin has been in business for over thirty-years as a small, solely owned pharmacy located in Philadelphia, Pennsylvania. Franklin developed a niche market in the field of infertility drugs through reputation and patient referrals. Franklin does not engage in extensive advertising and neither purchases advertising space in newspapers nor purchases television commercial time. Franklin has spent a total of $1,000.00 on advertising in the past four years. The extent of Franklin’s advertising budget is allocated to the maintenance of an information only Website on the Internet. Potential customers can view Franklin’s offerings but cannot utilize this Website to order or to purchase prescription drugs online. In addition, potential customers viewing the Website do not have the ability to contact Franklin via email and all prescription drug orders to Franklin must be made by post-jnail, telephone, or telefax and only with a doctor’s prescription.

The Times is a well known national newspaper that is published in New York. On October 25, 2000, The Times published an article entitled, A Web Bazaar Turns Into a Pharmaceutical Free For All (hereinafter “the Article”). The Article began with a description of the difficulties that a Yonkers, New York, mother had in obtaining expensive infertility medications and her use of the Internet to purchase the medication at a reasonable price. While the Article’s initial paragraphs mention the significant benefits that the Internet can offer when searching for prescriptions, such as comparative price shopping, convenience and anonymity, the remainder of the Article deals with the serious health risks and dangers of buying “E-medicines.” The Article described in detail “unscrupulous” and “cloak and dagger” Websites which take e-mail orders for con *430 trolled pharmaceuticals-infertility drugs, in particular-without requiring a doctor’s prescription. More specifically, the Article described “online pharmacies” as:

unscrupulous online pharmacies, eager to grab a slice of a global pharmaceutical market that exceeds $200 billion, intentionally muddy the water by operating multiple sites from numerous places, all of which can be shut down at a moment’s notice and moved elsewhere. The chaos created by these Web-based transactions, which can cross state and county borders, ensures that many investigations quickly become a jurisdictional nightmare.

The Article, col. 3-4, ¶ 1.

Although there was no specific reference to Franklin within the text of this Article, the Article did contain an edited version of Franklin’s “web-grab.” 1 The web-grab is juxtaposed with a side-bar labeled “Safety Tips for Buying E-Medicines,” where the Article’s author warns readers to “[ajvoid sites that fail or refuse to provide a United States address and phone number.” The web-grab as seen in the Article has been edited to delete Franklin’s address and telephone number. Moreover, the Article did state that “traditional brick-and-mortar drugstores,” such as “CVS, Drug Emporium and Walgreens for example,” do not operate outside the law, but the Article failed to list Franklin as a lawful pharmacy while using Franklin’s web-grab as an illustration of unlawful practices.

On October 25, 2000, Franklin’s owner, Ronald Cohen (“Cohen”), became aware of the Article after he received a call from a personal friend. Cohen reviewed the Article and then contacted The Times to complain that the cropped picture of Franklin’s Web-site in the Article falsely portrays Franklin as selling prescription drugs over the Internet. The Times did issue a correction on October 30, 2000 on the second page of the newspaper (page A2) in a special location devoted to corrections of prior articles. The correction stated:

[a] picture of a Website in the special E-commerce section on Wednesday, with an article about buying medicine over the Internet, was published in error. The site, for the Franklin Drug Center in Philadelphia, lists prices. Prescriptions must be faxed or mailed to the company which arranges payment off line. The company does not sell drugs online.

See Defendant’s Exhibit B.

Thereafter, Franklin filed the instant action for defamation and false light. This Court denied The Times’ Motion for Summary Judgment 2 in a previous Order dated February 12, 2003 and made the following findings: (1) the law of Pennsylvania shall apply to this matter, (2) the Article as published by The Times is capable of a defamatory meaning; (3) the Article and illustration applies to Franklin; and (4) Franklin is a private figure and not a *431 limited purpose public figure. The Times thereafter filed the instant motion for Certification of Interlocutory Appeal or, in the alternative, Reconsideration of the Times’ Motion for Summary Judgment. The Court will first address The Times’ Motion for Reconsideration.

II. THE TIMES’ SUMMARY JUDGMENT MOTION

The Times previously moved this Court for summary judgment pursuant to Federal Rule of Civil Procedure 56 on all remaining claims against them. 3 “The purpose of a motion for reconsideration is to correct manifest errors of law or fact or to present newly discovered evidence.” Moll v. Northern Telecom, Inc., No. Civ. A.94-5451, 1996 WL 11355, at *2 (E.D.Pa. Jan.3, 1996). In reconsidering an earlier summary judgment motion, the same summary judgment standard applies. Travelers Idem. Co. v. Fantozzi, 825 F.Supp. 80, 83 (E.D.Pa.1993).

This Court will enter summary judgment in a libel and defamation action “if the pleadings, depositions, answers to interrogatories, and admissions on file, together with affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to judgment as a matter of law.” Fed.R.Civ.P. 56(c); Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 256 n. 7, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986) (explaining the “general reluctance to grant special procedural protections to defendants in libel and defamation actions in addition to the constitutional protections embodied in the substantive laws”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wabote v. Ude
E.D. Pennsylvania, 2021
NOTHSTEIN v. USA CYCLING
E.D. Pennsylvania, 2020
AC2T, INC. v. PURRINGTON
E.D. Pennsylvania, 2020
RALSTON v. POULOS
E.D. Pennsylvania, 2019
Woods Servs., Inc. v. Disability Advocates, Inc.
342 F. Supp. 3d 592 (E.D. Pennsylvania, 2018)
Adelson v. Harris
973 F. Supp. 2d 467 (S.D. New York, 2013)
Mzamane v. Winfrey
693 F. Supp. 2d 442 (E.D. Pennsylvania, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
267 F. Supp. 2d 425, 32 Media L. Rep. (BNA) 1229, 2003 U.S. Dist. LEXIS 10617, 2003 WL 21404407, Counsel Stack Legal Research, https://law.counselstack.com/opinion/franklin-prescriptions-inc-v-the-new-york-times-co-paed-2003.